Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
酪氨酸激酶抑制剂与PD-(L)1阻断剂联合使用会增加PD-(L)1阻断治疗中甲状腺功能障碍的风险:一项前瞻性研究
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-024-03733-2.
Tomoko Kobayashi,Shintaro Iwama,Ayana Yamagami,Tetsushi Izuchi,Koji Suzuki,Koki Otake,Yoshinori Yasuda,Masahiko Ando,Takeshi Onoue,Takashi Miyata,Mariko Sugiyama,Daisuke Hagiwara,Hidetaka Suga,Ryoichi Banno,Tetsunari Hase,Naoki Nishio,Shoichiro Mori,Tomoya Shimokata,Tomoyasu Sano,Kaoru Niimi,Nobuhisa Yoshikawa,Shusuke Akamatsu,Yuichi Ando,Masashi Akiyama,Michihiko Sone,Makoto Ishii,Hiroshi Arima